HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

GM2 gangliosidosis in British Jacob sheep.

Abstract
GM2 gangliosidosis (Tay-Sachs disease) was diagnosed in 6- to 8-month-old pedigree Jacob lambs from two unrelated flocks presenting clinically with progressive neurological dysfunction of 10 day's to 8 week's duration. Clinical signs included hindlimb ataxia and weakness, recumbency and proprioceptive defects. Histopathological examination of the nervous system identified extensive neuronal cytoplasmic accumulation of material that stained with periodic acid--Schiff and Luxol fast blue. Electron microscopy identified membranous cytoplasmic bodies within the nervous system. Serum biochemistry detected a marked decrease in hexosaminidase A activity in the one lamb tested, when compared with the concentration in age matched controls and genetic analysis identified a mutation in the sheep hexa allele G444R consistent with Tay-Sachs disease in Jacob sheep in North America. The identification of Tay-Sachs disease in British Jacob sheep supports previous evidence that the mutation in North American Jacob sheep originated from imported UK stock.
AuthorsM E Wessels, J P Holmes, M Jeffrey, M Jackson, A Mackintosh, E H Kolodny, B J Zeng, C B Wang, S F E Scholes
JournalJournal of comparative pathology (J Comp Pathol) 2014 Feb-Apr Vol. 150 Issue 2-3 Pg. 253-7 ISSN: 1532-3129 [Electronic] England
PMID24309906 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCrown Copyright © 2013. Published by Elsevier Ltd. All rights reserved.
Chemical References
  • beta-Hexosaminidase alpha Chain
Topics
  • Animals
  • Gangliosidoses, GM2 (genetics, pathology, veterinary)
  • Mutation
  • Sheep
  • Sheep Diseases (genetics, pathology)
  • beta-Hexosaminidase alpha Chain (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: